Xylem (NYSE:XYL) Downgraded to Hold Rating by Zacks Research

Zacks Research cut shares of Xylem (NYSE:XYL) from a strong-buy rating to a hold rating in a research report sent to investors on Tuesday morning,Zacks.com reports.

Other equities analysts have also issued reports about the stock. TD Cowen lifted their price objective on shares of Xylem from $125.00 to $130.00 and gave the company a “hold” rating in a research report on Tuesday, August 26th. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a research note on Thursday, November 13th. Royal Bank Of Canada boosted their price target on shares of Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 29th. UBS Group raised their price objective on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday, November 6th. Finally, Mizuho set a $160.00 target price on Xylem in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $166.90.

Xylem Stock Performance

XYL stock traded up $1.29 during trading on Tuesday, hitting $140.27. The company had a trading volume of 133,473 shares, compared to its average volume of 1,393,218. The firm has a 50-day moving average price of $146.26 and a 200-day moving average price of $137.29. The company has a quick ratio of 1.43, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. The firm has a market cap of $34.15 billion, a PE ratio of 35.94, a price-to-earnings-growth ratio of 2.50 and a beta of 1.15. Xylem has a 1-year low of $100.47 and a 1-year high of $154.27.

Xylem (NYSE:XYL) last posted its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The company had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The firm’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same period last year, the firm earned $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, analysts expect that Xylem will post 4.65 earnings per share for the current year.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is presently 41.13%.

Insider Transactions at Xylem

In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the sale, the chief accounting officer owned 2,957 shares in the company, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the transaction, the executive vice president directly owned 31,250 shares of the company’s stock, valued at approximately $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 13,121 shares of company stock valued at $1,982,459 in the last quarter. 0.27% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Xylem

Several hedge funds have recently added to or reduced their stakes in XYL. AFG Fiduciary Services Limited Partnership acquired a new position in Xylem during the 2nd quarter valued at approximately $275,000. IFM Investors Pty Ltd lifted its holdings in Xylem by 11.6% in the second quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company’s stock worth $6,995,000 after purchasing an additional 5,617 shares during the period. Impax Asset Management Group plc increased its stake in Xylem by 13.7% during the 2nd quarter. Impax Asset Management Group plc now owns 5,499,688 shares of the industrial products company’s stock valued at $709,183,000 after buying an additional 663,191 shares during the period. Acadian Asset Management LLC bought a new stake in shares of Xylem during the 2nd quarter worth about $20,361,000. Finally, BROOKFIELD Corp ON lifted its stake in shares of Xylem by 26.5% in the 1st quarter. BROOKFIELD Corp ON now owns 16,375 shares of the industrial products company’s stock worth $1,956,000 after acquiring an additional 3,430 shares during the period. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.